Scarica l'app Stockscreener
9.84
2.48%
-0.25
Dopo l'orario di chiusura:
9.92
0.08
+0.81%
4 D Molecular Therapeutics Inc Borsa (FDMT) Ultime notizie
25,450 RSUs: 4DMT Grants Stock Awards to Three New Employees Under 2025 Inducement Plan - Stock Titan
How institutional ownership impacts 4D Molecular Therapeutics Inc. stockJuly 2025 Closing Moves & Safe Swing Trade Setup Alerts - newser.com
Wall Street Analysts See a 208.52% Upside in 4D Molecular Therapeutics (FDMT): Can the Stock Really Move This High? - sharewise.com
Why 4D Molecular Therapeutics Inc. stock remains on watchlistsWeekly Trade Report & AI Enhanced Market Trend Forecasts - newser.com
Can 4D Molecular Therapeutics Inc. stock resist sector downturnsJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
Applying big data sentiment scoring on 4D Molecular Therapeutics Inc.Trade Risk Summary & Daily Technical Forecast Reports - newser.com
Identifying reversal signals in 4D Molecular Therapeutics Inc.Portfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
4D Molecular Therapeutics Officer Sells Shares - TradingView
4D Molecular Therapeutics insider sale: 2,408 shares at $10 - Stock Titan
Will 4D Molecular Therapeutics Inc. outperform the marketMarket Performance Report & Verified Short-Term Trading Plans - newser.com
Retinitis Pigmentosa Market to Expand Significantly by 2034, States DelveInsight Report | SparingVision SAS, ProQR Therapeutics NV, Viridian Therapeutics Inc, 4D Molecular Therapeutics Inc - The Globe and Mail
4D Molecular Therapeutics to Participate in Chardan’s 9th Annual Genetic Medicines Conference Panel Discussions - Quiver Quantitative
Can momentum traders help lift 4D Molecular Therapeutics Inc.Quarterly Investment Review & Daily Stock Trend Reports - newser.com
4D Molecular Therapeutics, Inc. announced that it expects to receive $11 million in funding from Cystic Fibrosis Foundation - MarketScreener
4D Molecular Therapeutics Receiving $11 Million in Funding for Cystic Fibrosis Study - MarketScreener
Published on: 2025-10-13 08:38:02 - newser.com
Is it too late to sell 4D Molecular Therapeutics Inc.Market Rally & Weekly Breakout Opportunity Watchlist - newser.com
4D Molecular (FDMT) Gains $11M Support for Cystic Fibrosis Treat - GuruFocus
Is it time to cut losses on 4D Molecular Therapeutics Inc.Trade Signal Summary & Risk Managed Investment Strategies - newser.com
4D Molecular Therapeutics, Inc. Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation - MarketScreener
4D Molecular Therapeutics, Inc.Common Stock (NQ: FDMT - FinancialContent
When is the best time to exit 4D Molecular Therapeutics Inc.Rate Hike & Risk Managed Investment Entry Signals - newser.com
FDMT insider files initial ownership; options at $22.69, $4.14 - Stock Titan
Momentum divergence signals in 4D Molecular Therapeutics Inc. chart2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
Will 4D Molecular Therapeutics Inc. see short term momentumJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - newser.com
4D Molecular Therapeutics Inc Stock Analysis and ForecastGlobal Market Influence & Access Powerful Market Insights - earlytimes.in
Real time alert setup for 4D Molecular Therapeutics Inc. performancePortfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com
What drives 4D Molecular Therapeutics Inc stock priceTrade Execution Strategies & Free Stock Chart Pattern Guides - earlytimes.in
Statistical indicators supporting 4D Molecular Therapeutics Inc.’s strength2025 Valuation Update & Weekly High Return Opportunities - newser.com
4D Molecular Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:FDMT - Benzinga
4D Molecular Therapeutics Appoints New Financial Officer - MSN
Is 4D Molecular Therapeutics (NASDAQ:FDMT) In A Good Position To Invest In Growth? - Yahoo Finance
How 4D Molecular Therapeutics Inc. stock responds to policy changesJuly 2025 Outlook & Technical Pattern Based Buy Signals - newser.com
What MACD signals say about 4D Molecular Therapeutics Inc.2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com
What the charts say about 4D Molecular Therapeutics Inc. todayProduct Launch & Accurate Buy Signal Alerts - newser.com
4D Molecular Therapeutics says on Sept 30, appointed Ashoo Gupta as principal financial officerSEC filing - MarketScreener
4D Molecular Therapeutics, Inc. Appoints Ashoo Gupta as Principal Accounting Officer, Effective September 30, 2025 - MarketScreener
4D Molecular Therapeutics: This Gene Therapy Company May Soon Surprise Investors (NASDAQ:FDMT) - Seeking Alpha
What analysts say about 4D Molecular Therapeutics Inc stockMarket Insider Reports & Free Explosive Wealth Accumulation - earlytimes.in
Is 4D Molecular Therapeutics Inc. stock reversal real or fakeWeekly Stock Summary & Consistent Growth Equity Picks - newser.com
News impact scoring models applied to 4D Molecular Therapeutics Inc.July 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
Bizily Scott sells 4D Molecular Therapeutics (FDMT) stock worth $19,256 By Investing.com - Investing.com Canada
Bizily Scott sells 4D Molecular Therapeutics (FDMT) stock worth $19,256 - Investing.com India
1.84%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):